Abstract
The title compounds were synthesized by a three-component reaction of 4-hydroxycoumarin, aromatic amines and α,β-epoxy ketones, catalyzed by ZnO-ZnAl2O4 nanocomposite.
Introduction
Few reports have been published on the synthesis of furo[3,2-c]chromen-4-one derivatives. These compounds are known for their antimicrobial [1], anti-inflammatory [2], antiviral [3] and antibacterial activities and are DNA intercalating agents [4]. Their synthesis involves a four-component reaction of nitrostyrenes, aromatic aldehydes, coumarins and ammonium acetate [5], a Bu3P-mediated C-acylation/cyclization approach [6], a three-component reaction of 2,4′-dibromoacetophenone, benzaldehydes and 4-hydroxycoumarin under microwave irradiation [7], radical cyclization of hydroxyenones with electron-rich alkenes [8] and a Pd-catalyzed cascade of 1,4-addition and cyclization [9], among others. The three-component reaction of aromatic amines, 4-hydroxycoumarin and α,β-epoxy ketones leading to the formation of 3-aryl-2-[(aryl)-(arylamino)]methyl-4H-furo[3,2-c]chromen-4-ones, as reported in this paper, has not been previously described. This work is a continuation of our efforts devoted to the improved synthesis of heterocyclic motifs [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22].
Results and discussion
ZnO-ZnAl2O4 nanocomposite was prepared through co-precipitation from an equimolar solution of zinc acetate and aluminum nitrate. The surface morphology and particle size analysis were performed using field emission-scanning electron microscopy (FE-SEM) and dynamic light scattering (DLS) techniques and the results are shown in Figure 1. FE-SEM images show that the nanocomposite is composed of amorphous particles and is a homogenized mixture of ZnO and ZnAl2O4 phases. The prepared nanoparticles were evaluated by X-ray diffraction (XRD). Although the broad peaks of zinc aluminate cover the peaks of zinc oxide, the XRD pattern is consistent with the formation of the two-phase nano-zinc oxide and zinc aluminate. The hexagonal phase of ZnO is characterized by peaks at 31.8, 34.3, 36.5, 47.6, 57.2, 63.2 and 67.9 [2θ°]. Zinc aluminate is characterized by peaks at 31.4, 36.8, 44.8, 47.6, 49.2, 55.7, 59.6, 62.7, 65.2 and 77.5 [2θ°], which shows a cubic phase.

XRD pattern, FE-SEM photographs and particle size distribution of ZnO-ZnAl2O4 nanocomposite.
The DLS technique was used to determine the particle size distribution. The results show that the samples consist of particles <100 nm in size. Before analysis, the sample was dispersed in ethanol (1 g in 25 mL) and sonicated for 30 min. The mean particle size determined by this method was 56 nm.
The condensation reaction of phenyl(3-phenyloxiran-2-yl)methanone (3a, 1 mmol), 4-hydroxycoumarin (2, 1 mmol) and aniline (1, 1 mmol) in the presence of the catalyst (Scheme 1) was investigated as a model reaction under solvent-free conditions and in different solvents including H2O, EtOH, aqueous EtOH (50%), n-hexane and CH2Cl2. The temperature and the amount of catalyst were also varied. In solution, the reaction was successful only in aqueous ethanol, furnishing the product in a 22% yield. Under optimized conditions, the solvent-free reaction leading to 4a was conducted at 120°C. Following these optimization studies, various derivatives of the 3-aryl-2-[(aryl)(arylamino)]methyl-4H-furo[3,2-c]chromen-4-ones were prepared. In all cases, the reaction proceeded well and the products were obtained in moderate to good yields.

Catalytic three-component reactions of aromatic amines, 4-hydroxycoumarin and α,β-epoxy ketones using ZnO-ZnAl2O4 nanocomposite as a catalyst.
Finally, the catalyst was recovered from the reaction medium by filtration and used for new reactions. It was found that the catalyst could be reused for five successive runs without loss of its catalytic activity.
Conclusion
A novel one-pot three-component reaction of aromatic amines, 4-hydroxycoumarin and α,β-epoxy ketones under solvent-free conditions at 120°C in the presence of ZnO-ZnAl2O4 nanocomposite as a heterogeneous catalyst furnishes furo[3,2-c]chromen-4-ones 4a–i.
Experimental
The powder XRD patterns were measured with a D8-Advance diffractometer (Bruker) using Cu-Kα irradiation. The 1H nuclear magnetic resonance (NMR) (400 MHz) and 13C NMR (100 MHz) spectra were recorded on a Bruker Avance DPX 400 instrument. The spectra were measured in dimethyl sulfoxide-d6 (DMSO-d6) relative to tetramethylsilane (TMS). Elemental analysis was performed on a Heraeus CHN-O-Rapid analyzer. The powder XRD patterns were measured with a D8-Advance diffractometer (Bruker) using Cu-Kα irradiation. FE-SEM and energy dispersive X-ray analysis measurements were taken on a Hitachi S-4160 instrument to examine the shape and metallic composition of the samples.
Preparation of ZnO-ZnAl2O4 nanocomposite
Zinc acetate (20 mmol) and aluminum nitrate (20 mmol) were dissolved in 100 mL of water in a 250-mL beaker (solution A). In a separate beaker, 2-aminoethanol (120 mmol) was dissolved in a mixture of water (50 mL) and glycerine (10 mL) (solution B). Solution B was slowly added dropwise to the solution A under vigorous magnetic stirring. The mixture was continuously stirred for another 60 min. The resulting precipitate was filtered, washed with water several times, dried in an oven and finally calcined at 700°C for 2 h.
Preparation of compounds 4a–i
A mixture of aromatic amine 1 (1.0 mmol), 4-hydroxycoumarin (2, 1.0 mmol), α,β-epoxy ketone 3 (1 mmol) and ZnO-ZnAl2O4 nanocomposite (0.025 g) was heated at 120°C for 3 h. After the completion of the reaction, as monitored by thin-layer chromatography (TLC) eluting with EtOAc/hexane (1:9), the resultant solid was dissolved in hot ethanol, and the solution was filtered and concentrated. The product 4a–i was crystallized from ethanol.
3-Phenyl-2-[(phenyl)(phenylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4a)
Yield 69%; mp 257–259°C; 1H NMR: δ 4.22 (s, 1H, NH), 6.19 (s, 1H, CH), 6.89 (t, 1H, J=7.8 Hz), 7.06–7.67 (m, 17H), 7.83 (d, 1H, J=8.2 Hz) ); 13C NMR: δ 58.3, 113.7, 114.2, 114.8, 117.1, 123.6, 123.9, 124.7, 126.9, 127.4, 128.2, 128.5, 128.9, 129.1, 129.2, 129.5, 131.3, 132.8, 139.6, 143.7, 151.6, 152.9, 158.6, 160.1. Anal. Calcd for C30H21NO3: C, 81.25; H, 4.77; N, 3.16%. Found: C, 81.19; H, 4.68; N, 3.14.
3-Phenyl-2-[(phenyl)(2,4-dichlorophenylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4b)
Yield 22%; mp >300°C; 1H NMR: δ 4.37 (s, 1H, NH), 6.15 (s, 1H, CH), 6.97 (d, 1H, J=7.8 Hz), 7.10–7.62 (m, 15H), 7.81 (d, 1H, J=8.4 Hz) ); 13C NMR: δ 58.6, 114.1, 114.8, 117.0, 117.2, 122.9, 123.5, 123.9, 126.9, 127.4, 128.2, 128.5, 128.8, 129.1, 129.2, 129.4, 130.6, 131.3, 132.8, 135.3, 139.7, 151.5, 152.9, 158.5, 159.9. Anal. Calcd for C30H19Cl2NO3: C, 70.32; H, 3.74; N, 2.73. Found: C, 70.19; H, 3.68; N, 2.63.
3-Phenyl-2-[(phenyl)(4-nitrophenylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4c)
Yield 50%; mp >300°C; 1H NMR: δ 4.89 (s, 1H, NH), 6.19 (s, 1H, CH), 7.07–7.62 (m, 15H), 7.82 (d, 1H, J=8.4 Hz), 8.09 (d, 2H, J=8.0 Hz); 13C NMR: δ 58.9, 113.9, 114.6, 116.9, 117.3, 118.8, 123.4, 123.8, 126.9, 127.4, 128.4, 128.5, 128.9, 129.1, 129.4, 131.5, 132.7, 139.5, 140.7, 144.1, 151.6, 152.8, 158.7, 160.4 Anal. Calcd for C30H20N2O5: C, 73.76; H, 4.13; N, 5.73. Found: C, 73.63; H, 4.01; N, 5.67.
3-Phenyl-2-[(phenyl)(cyclohexylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4d)
Yield 43%; mp 203–205°C; 1H NMR: δ 1.25–1.71 (m, 10H), 2.61–2.64 (m, 1H), 4.02 (s, 1H, NH), 6.01 (s, 1H, CH), 7.16–7.66 (m, 13H), 7.82 (d, 1H, J=8.3 Hz); 13C NMR: δ 25.3, 26.4, 34.7, 53.9, 58.3, 113.7, 114.0, 116.9, 123.5, 123.9, 126.9, 127.7, 128.2, 128.5, 128.8, 129.0, 129.4, 131.5, 132.7, 139.4, 151.5, 152.7, 158.6, 159.8. Anal. Calcd for C30H27NO3: C, 80.15; H, 6.05; N, 3.12. Found: C, 80.19; H, 6.05; N, 3.14.
3-Phenyl-2-[(phenyl)(2-methoxyphenylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4e)
Yield 57%; mp 237–239°C; 1H NMR: δ 3.81 (s, 3H, OCH3), 4.19 (s, 1H, NH), 6.13 (s, 1H, CH), 6.84–6.99 (m, 4H), 7.14–7.66 (m, 13H), 7.82 (d, 1H, J=8.4 Hz); 13C NMR: δ 56.3, 58.4, 110.9, 114.0, 114.5, 116.8, 118.1, 121.9, 123.4, 123.5, 123.8, 127.0, 127.1, 127.4, 127.6, 128.5, 128.7, 128.9, 129.0, 129.3, 131.5, 132.8, 139.5, 147.8, 151.6, 152.6, 158.5, 160.1. Anal. Calcd for C31H23NO4: C, 78.63; H, 4.90; N, 2.96. Found: C, 78.51; H, 4.77; N, 2.88.
3-(4-Chlorophenyl)-2-[(phenyl)(phenylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4f)
Yield 76%; mp 276–278°C; 1H NMR: δ 4.23 (s, 1H, NH), 6.10 (s, 1H, CH), 6.89 (t, 1H, J=7.8 Hz), 7.02–7.54 (m, 16H), 7.80 (d, 1H, J=8.6 Hz); 13C NMR: δ 58.3, 113.4, 113.8, 114.1, 116.7, 123.2, 123.7, 124.7, 126.9, 128.3, 128.5, 128.9, 129.1, 129.2, 129.5, 131.5, 132.8, 135.7, 139.4, 144.0, 151.5, 152.3, 158.7, 160.2. Anal. Calcd for C30H20ClNO3: C, 75.39; H, 4.22; N, 2.93. Found: C, 75.33; H, 4.16; N, 2.85.
3-(4-Chlorophenyl)-2-[(phenyl)(p-tolylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4g)
Yield 77%; mp 283–285°C; 1H NMR: δ 2.19 (s, 3H, CH3), 4.28 (s, 1H, NH), 6.07 (s, 1H, CH), 6.68 (d, 2H, J=7.8 Hz), 7.06 (d, 2H, J=7.8 Hz), 7.11–7.54 (m, 12H), 7.81 (d, 1H, J=8.4 Hz); 13C NMR: δ 21.4, 58.4, 113.8, 114.3, 114.3, 116.6, 123.4, 123.6, 126.9, 128.4, 128.7, 128.9, 129.2, 129.5, 129.6, 131.5, 132.5, 132.7, 135.6, 139.5, 144.1, 151.6, 152.3, 158.7, 160.1. Anal. Calcd for C31H22ClNO3: C, 75.68; H, 4.51; N, 2.85. Found: C, 75.60; H, 4.46; N, 2.79.
3-(4-Chlorophenyl)-2-[(phenyl)(4-methoxyphenylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4h)
Yield 83%; mp 288–290°C; 1H NMR: δ 3.74 (s, 3H, OCH3), 4.23 (s, 1H, NH), 6.06 (s, 1H, CH), 6.85 (d, 2H, J=7.8 Hz), 6.97 (d, 2H, J=7.8 Hz), 7.11–7.54 (m, 12H), 7.81 (d, 1H, J=8.4 Hz); 13C NMR: δ 56.1, 58.4, 113.9, 114.2, 114.4, 116.3, 116.6, 123.4, 123.6, 126.9, 128.4, 128.7, 128.9, 129.5, 129.6, 131.5, 132.7, 135.7, 139.5, 144.1, 151.6, 152.3, 157.7, 158.6, 160.2. Anal. Calcd for C31H22ClNO4: C, 73.30; H, 4.37; N, 2.76. Found: C, 73.30; H, 4.37; N, 2.76.
3-(4-Chlorophenyl)-2-[(phenyl)(4-chlorophenylamino)]methyl-4H-furo[3,2-c]chromen-4-one (4i)
Yield 70%; mp >300°C; 1H NMR: δ 4.39 (s, 1H, NH), 6.10 (s, 1H, CH), 6.52 (d, 2H, J=7.6 Hz), 7.12–7.54 (m, 14H), 7.81 (d, 1H, J=8.6 Hz); 13C NMR: δ 58.5, 113.9, 114.4, 116.5, 119.8, 123.2, 123.8, 126.9, 128.4, 128.8, 129.0, 129.2, 129.4, 129.6, 130.0, 131.4, 132.8, 135.9, 139.7, 144.1, 151.5, 152.4, 158.7, 160.2. Anal. Calcd for C30H19Cl2NO3: C, 70.32; H, 3.74; N, 2.73. Found: C, 70.27; H, 3.68; N, 2.70.
Acknowledgments
We are thankful to the Najafabad Branch of the Islamic Azad University Research Council for partial support of this research.
References
[1] Kale, A.; Bingi, C.; Sripada, S.; Kumar, C. G.; Atmakur, K. A simple, one pot synthesis of furo[3,2-c]chromenes and evaluation of antimicrobial activity. Bioorg. Med. Chem. Lett.2016, 26, 4899–4902.10.1016/j.bmcl.2016.09.022Search in Google Scholar
[2] Mercep, M.; Mesic, M.; Hrvacic, B.; Elenkov, I. J.; Malnar, I. Furochromene derivative with anti-inflammatory activity, WO2005/095411A1, 2005.Search in Google Scholar
[3] Trkovnik, M.; Cacic, M.; Rizvani, J. Coumarin derivative as antiviral agent, pharmaceutical composition thereof, its preparation and use, WO 2016156888 A1, 2016.Search in Google Scholar
[4] Al-Sehemi, A. G.; El-Gogary, S. R. Synthesis and photooxygenation of furo[3,2-c]coumarin derivatives as antibacterial and DNA intercalating agent. Chin. J. Chem.2012, 30, 316–320.10.1002/cjoc.201180483Search in Google Scholar
[5] Zhou, Z.; Liu, H.; Li, Y.; Liu, J.; Li, Y.; Liu, J.; Yao, J.; Wang, C. Novel synthesis of substituted furo[3,2-c]chromen-4-ones via four-component reaction from substituted nitrostyrenes, aromatic aldehydes, coumarins, and ammonium acetate. ACS Comb. Sci.2013, 15, 363–369.10.1021/co4000419Search in Google Scholar
[6] Lee, C.-J.; Tsai, C.-C.; Hong, S.-H.; Chang, G.-H.; Yang, M.-C.; Möhlmann, L.; Lin, W. Preparation of furo[3,2-c]coumarins from 3-cinnamoyl-4-hydroxy-2H-chromen-2-ones and acyl chlorides: a Bu3P-mediated C-acylation/cyclization sequence. Angew. Chem. Int. Ed.2015, 54, 8502–8505.10.1002/anie.201502789Search in Google Scholar
[7] Safaei-Ghomi, J.; Babaei, P.; Shahbazi-Alavi, H.; Pyne, S. G.; Willis, A. C. A concise synthesis of furo[3,2-c]coumarins catalyzed by nanocrystalline ZnZr4(PO4)6 ceramics under microwave irradiation. J. Iran. Chem. Soc.2016, 13, 1439–1448.10.1007/s13738-016-0859-1Search in Google Scholar
[8] Yılmaz, M.; Yakut, M.; Tarık Pekel, A. Synthesis of 2,3-dihydro-4H-furo[3,2-c] chromen-4-ones and 2,3-dihydronaphtho[2,3-b]furan-4,9-diones by the radical cyclizations of hydroxyenones with electron-rich alkenes using manganese(III) acetate. Synth. Commun.2008, 38, 914–927.10.1080/00397910701845456Search in Google Scholar
[9] Zhao, L.; Cheng, G.; Hu, Y. A novel multicomponent reaction to synthesize substituted furo[3,2-c]chromenes via a Pd-catalyzed cascade process. Tetrahedron Lett.2008, 49, 7364–7367.10.1016/j.tetlet.2008.10.025Search in Google Scholar
[10] Ghashang, M.; Mansoor, S. S.; Aswin, K. Thiourea dioxide: an efficient and reusable organocatalyst for the rapid one-pot synthesis of pyrano[4,3-b]pyran derivatives in water. Chin. J. Catal.2014, 35, 127–133.10.1016/S1872-2067(12)60727-XSearch in Google Scholar
[11] Ghashang, M.; Mansoor, S. S.; Mohammad Shafiee, M. R.; Kargar, M.; Najafi Biregan, M.; Azimi, F.; Taghrir, H. Green chemistry preparation of MgO nanopowders: efficient catalyst for the synthesis of thiochromeno [4,3-b]pyran and thiopyrano[4,3-b] pyran derivatives. J. Sulfur Chem.2016, 37, 377–390.10.1080/17415993.2016.1149856Search in Google Scholar
[12] Ghashang, M. ZnAl2O4–Bi2O3 composite nano-powder as an efficient catalyst for the multi-component, one-pot, aqueous media preparation of novel 4H-chromene-3-carbonitriles. Res. Chem. Intermed.2016, 42, 4191–4205.10.1007/s11164-015-2269-xSearch in Google Scholar
[13] Ghashang, M.; Mansoor, S. S.; Shams Solaree, L.; Sharifian-esfahani, A. Multi-component, one-pot, aqueous media preparation of dihydropyrano [3, 2-c] chromene derivatives over MgO nanoplates as an efficient catalyst. Iran. J. Catal.2016, 6, 237–243.Search in Google Scholar
[14] Baziar, A.; Ghashang, M. Preparation of pyrano [3, 2-c] chromene-3-carbonitriles using ZnO nano-particles: a comparison between the Box–Behnken experimental design and traditional optimization methods. React. Kinet. Mech. Catal.2016, 118, 463–479.10.1007/s11144-016-1013-xSearch in Google Scholar
[15] Ghashang, M.; Kargar, M.; Shafiee, M. R. M.; Mansoor, S. S.; Fazlinia, A.; Esfandiari, H. CuO nano-structures prepared in rosmarinus officinalis leaves extract medium: efficient catalysts for the aqueous media preparation of dihydropyrano [3, 2-c] chromene derivatives. Recent Pat. Nanotechnol.2015, 9, 204–211.10.2174/1872210510999151126110657Search in Google Scholar PubMed
[16] Shafiee, M. R. M.; Ghashang, M.; Fazlinia, A. Preparation of 1, 4-dihydropyridine derivatives using perchloric acid adsorbed on magnetic Fe3O4 nanoparticles coated with silica. Curr. Nanosci.2013, 9, 197–201.10.2174/1573413711309020006Search in Google Scholar
[17] Behmaneshfar, A.; Ghashang, M.; Mohammad Shafiee, M. R.; Saffar-Teluri, A.; Fazlinia, A.; Esfandiari, H. Optimization of the preparation condition of 2,4,5-triphenyl-1H-imidazole over BaSO4 nanoparticles as catalyst using a response surface methodology (RSM). Curr. nanoSci. 2015, 11, 56–63.10.2174/1573413710666140923211414Search in Google Scholar
[18] Taghrir, H.; Ghashang, M.; Biregan, M. N. Preparation of 1-amidoalkyl-2-naphthol derivatives using barium phosphate nano-powders. Chin. Chem. Lett.2016, 27, 119–126.10.1016/j.cclet.2015.08.011Search in Google Scholar
[19] Mohammad Shafiee, M. R.; Kargar, M.; Hashemi, M. S.; Ghashang, M. Green synthesis of NiFe2O4/Fe2O3/CeO2 nanocomposite in a walnut green hulls extract medium: magnetic properties and characterization. Curr. Nanosci.2016, 12, 645–649.10.2174/1573413712666160513124809Search in Google Scholar
[20] Ghashang, M. Bi2O3 nano-particles as an efficient catalyst for the multi-component, one-pot, aqueous media preparation of benzo[h]pyrano[3,2-c]chromene-2-carbonitriles and pyrano[3,2-g]chromene-7-carbonitriles. Biointerface Res. Appl. Chem.2016, 6, 1338–1344.10.1007/s11164-015-2269-xSearch in Google Scholar
[21] Zare, M.; Ghashang, M.; Saffar-Teluri, A. BaO-ZnO nano-composite efficient catalyst for the photo-catalytic degradation of 4-chlorophenol. Biointerface Res. Appl. Chem.2016, 6, 1049–1052.Search in Google Scholar
[22] Ghashang, M.; Jabbarzare, S.; Tavakoli, H.; Banisadeghi, H.; Sokhanvar, A. H.; Lotfi, M.; Chami, A. Growth of the nano-islands of barium aluminum oxide nano-spheres on the surface of Al2O3-MgO composite: preparation and evaluation of their catalytic activity. Curr. Nanosci.2015, 11, 95–100.10.2174/1573413710666140722174725Search in Google Scholar
©2018 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Research progress in quinazoline derivatives as multi-target tyrosine kinase inhibitors
- Research Articles
- A bio-inspired approach to proline-derived 2,4-disubstituted oxazoles
- Solvent-free preparation of 3-aryl-2-[(aryl)(arylamino)]methyl-4H-furo[3,2-c]chromen-4-one derivatives using ZnO-ZnAl2O4 nanocomposite as a heterogeneous catalyst
- Synthesis of 4-arylethyl-6-arylpyrimidine-2-thiols through aza-Michael addition/nucleophilic addition/aromatization tandem reactions
- 3-Carboxy-1-sulfopyridin-1-ium chloride ([CPySO3H]+Cl−): an efficient catalyst for one-pot synthesis of hexahydroquinoline-3-carboxamides
- Synthesis of new 3H-chromeno[2,3-d]pyrimidine-4,6(5H,7H)-diones via the tandem intramolecular Pinner/Dimroth rearrangement
- A new synthesis of pyrrolo[3,2-d]pyrimidine derivatives by a one-pot, three-component reaction in the presence of L-proline as an organocatalyst
- Diversity-oriented synthesis of amide derivatives of tricyclic thieno[2,3-d]pyrimidin-4(3H)-ones and evaluation of their influence on melanin synthesis in murine B16 cells
- Synthesis, crystal structure, molecular docking studies and bio-evaluation of some N4-benzyl-substituted isatin- 3-thiosemicarbazones as urease and glycation inhibitors
- Ultrasound-assisted synthesis and antimicrobial activity of tetrazole-based pyrazole and pyrimidine derivatives
Articles in the same Issue
- Frontmatter
- Review
- Research progress in quinazoline derivatives as multi-target tyrosine kinase inhibitors
- Research Articles
- A bio-inspired approach to proline-derived 2,4-disubstituted oxazoles
- Solvent-free preparation of 3-aryl-2-[(aryl)(arylamino)]methyl-4H-furo[3,2-c]chromen-4-one derivatives using ZnO-ZnAl2O4 nanocomposite as a heterogeneous catalyst
- Synthesis of 4-arylethyl-6-arylpyrimidine-2-thiols through aza-Michael addition/nucleophilic addition/aromatization tandem reactions
- 3-Carboxy-1-sulfopyridin-1-ium chloride ([CPySO3H]+Cl−): an efficient catalyst for one-pot synthesis of hexahydroquinoline-3-carboxamides
- Synthesis of new 3H-chromeno[2,3-d]pyrimidine-4,6(5H,7H)-diones via the tandem intramolecular Pinner/Dimroth rearrangement
- A new synthesis of pyrrolo[3,2-d]pyrimidine derivatives by a one-pot, three-component reaction in the presence of L-proline as an organocatalyst
- Diversity-oriented synthesis of amide derivatives of tricyclic thieno[2,3-d]pyrimidin-4(3H)-ones and evaluation of their influence on melanin synthesis in murine B16 cells
- Synthesis, crystal structure, molecular docking studies and bio-evaluation of some N4-benzyl-substituted isatin- 3-thiosemicarbazones as urease and glycation inhibitors
- Ultrasound-assisted synthesis and antimicrobial activity of tetrazole-based pyrazole and pyrimidine derivatives